Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Van ‘T Veer, W."'
Publikováno v:
Avian Pathology; Oct1989, Vol. 18 Issue 4, p591-595, 5p
Autor:
Lucchinetti, Eliana, Lou, Phing‐How, Wawrzyniak, Paulina, Wawrzyniak, Marcin, Scharl, Michael, Holtzhauer, Gregory A., Krämer, Stefanie D., Hersberger, Martin, Rogler, Gerhard, Zaugg, Michael
Publikováno v:
Molecular Nutrition & Food Research; Mar2021, Vol. 65 Issue 5, p1-18, 18p
Autor:
Wit, J. J. De
Publikováno v:
Avian Pathology. Apr2000, Vol. 29 Issue 2, p71-93. 23p.
Autor:
Hampson, D. J., Mclaren, A. J.
Publikováno v:
Avian Pathology. Apr99, Vol. 28 Issue 2, p113-117. 5p.
Publikováno v:
Avian Pathology. Sep1994, Vol. 23 Issue 3, p461-470. 10p.
Publikováno v:
Avian Pathology. Dec1993, Vol. 22 Issue 4, p693-701. 9p.
Publikováno v:
Avian Pathology. Dec1992, Vol. 21 Issue 4, p559-568. 10p.
Autor:
Molly Klein, Alexander D. Borowsky, Gregor Krings, Ronald Balassanian, I Tolgay Ocal, Sunati Sahoo, Denise M. Wolf, Kimberley Cole, Shuko Harada, Amy L. Delson, Laura van 't Veer, Kamaljeet Singh, Kimmie Rabe, W. Fraser Symmans, Sara J. Venters, Sonal Shad, Yunn-Yi Chen, Laura J. Esserman, Malini Harigopal, Lamorna Brown-Swigart, Jodi M. Carter, Laila Khazai
Publikováno v:
Cancer Research. 81:PS4-09
Background: I-SPY 2 is a neoadjuvant platform trial open to patients with locally advanced, molecular high-risk breast cancer. In a concerted pursuit of mid-therapy response biomarkers, we evaluated inter-regimen biopsies, to identify patients who ma
Autor:
Sonal Shad, Nola M. Hylton, Alexander D. Borowsky, David C. Newitt, Shuko Harada, Sara J. Venters, Ronald Balassanian, Molly Klein, I Tolgay Ocal, Sunati Sahoo, Wen Li, Kamaljeet Singh, Kimmie Rabe, Amy L. Delson, Laura van 't Veer, Christina Yau, Gregor Krings, W. Fraser Symmans, Natsuko Onishi, Kimberley Cole, Jessica Gibbs, Jodi M. Carter, Laila Khazai, Malini Harigopal, Barbara LeStage, Yunn-Yi Chen, Denise M. Wolf, Sandra Finestone, Laura J. Esserman, Lamorna Brown-Swigart
Publikováno v:
Cancer Research. 81:PS4-10
Background: The I-SPY 2 TRIAL, open to patients with locally advanced, molecular high-risk breast cancer, aims to bring each patient to pathologic complete response (pCR) with a minimum of toxicity. Here we test the hypothesis that imaging (MR volume
Autor:
Dentener, M. A., Creutzberg, E. C., Schols, A. M. W. J., Mantovani, A., van't#Veer, C., Buurman, W. A., Wouters, E. F. M., Schols, A M, Wouters, E F
Publikováno v:
Thorax; Sep2001, Vol. 56 Issue 9, p721-726, 6p